In This Article:
Quanzhou, China, Jan. 03, 2025 (GLOBE NEWSWIRE) -- INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares began trading on the Nasdaq Capital Market on January 2, 2025 under the ticker symbol “INLF.”
The Company received aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses payable by the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary shares at the public offering price, less underwriting discounts.
Net proceeds from the Offering will be used for (i) the construction of a 5G digital intelligent equipment production base; (ii) establishing 24 local marketing and service offices within the PRC; (iii) the construction of an industrial robot and automation application technology research and development center; and (iv) working capital.
The Offering was conducted on a firm commitment basis. AC Sunshine Securities LLC acted as underwriter for the Offering (the “Underwriter”). Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and iTKG Law LLC acted as U.S. counsel to the Underwriter in connection with the Offering.
A registration statement on Form F-1 relating to the Offering was filed with the U.S. Securities and Exchange Commission (the “SEC”) (File Number: 333-279569) and was declared effective by the SEC on December 20, 2024. The Offering is being made only by means of a prospectus, forming a part of the registration statement. Copies of the prospectus relating to the Offering may be obtained from AC Sunshine Securities LLC, Attn: 200 E. Robinson Street, Suite 295, Orlando, FL 32801, or by email at prospectus@acsunshine.com, or by calling +1(689)-867-6218. In addition, copies of the prospectus relating to the Offering may be obtained via the SEC’s website at www.sec.gov.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.